Akebia Therapeutics Inc. (AKBA) announced Tuesday morning that it has entered into a collaboration and license agreement with Otsuka Pharmaceutical to develop and commercialize vadadustat in the U.S.
from RTT - Before the Bell http://ift.tt/2i0fSRm
via IFTTT
No comments:
Post a Comment